Predictive Value of Circulating Tumor Cells and Circulating Free DNA in NSCLC Patients Treated with Nivolumab

被引：0
|
作者：
Rossi, G. [1 ]
Tagliamento, M. [1 ]
Alama, A. [1 ]
Coco, S. [1 ]
Genova, C. [1 ]
Rijavec, E. [1 ]
Barletta, G. [1 ]
Biello, F. [1 ]
Vanni, I. [1 ]
Boccardo, S. [1 ]
Dal Bello, M. G. [1 ]
Alessandra, R. [2 ]
Fontana, V. [2 ]
Grossi, F. [1 ]
机构：
[1] Osped Policlin San Martino, Lung Canc Unit, Genoa, Italy
[2] Osped Policlin San Martino, Clin Epidemiol Unit, Genoa, Italy
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
circulating free DNA; Circulating tumor cells; Immunotherapy;
D O I：
10.1016/j.jtho.2018.08.1226
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.04-02
引用
收藏
页码：S730 / S731
页数：2
相关论文
共 50 条
  • [1] Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with nivolumab
    Passiglia, F.
    Perez, A.
    Listi, A.
    Castiglia, M.
    Musso, E.
    Ancona, C.
    Rizzo, S.
    Alu, M.
    Blasi, L.
    Russo, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [2] Predictive impact of PD-L1-expressing circulating tumor cells in NSCLC patients treated with nivolumab
    Shibaki, Ryota
    Koh, Yasuhiro
    Akamatsu, Hiroaki
    Kurita, Kazuki
    Yagi, Satomi
    Kanai, Kuninobu
    Hayata, Atsushi
    Tokudome, Nahomi
    Higuchi, Masayuki
    Kanbara, Hisashige
    Akamatsu, Keiichiro
    Ueda, Hiroki
    Nakanishi, Masanori
    Yamamoto, Nobuyuki
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [3] Predictive impact of PD-L1-expressing circulating tumor cells in NSCLC patients treated with nivolumab
    Yasuhiro, Koh
    Akamatsu, Hiroaki
    Kurita, Kazuki
    Yagi, Satomi
    Kanai, Kuninobu
    Hayata, Atsushi
    Tokudome, Nahomi
    Higuchi, Masayuki
    Kanbara, Hisashige
    Akamatsu, Keiichiro
    Ueda, Hiroki
    Nakanishi, Masanori
    Yamamoto, Nobuyuki
    CANCER SCIENCE, 2018, 109 : 1098 - 1098
  • [4] Predictive impact of sequential evaluation of PD-L1-expressing circulating tumor cells in NSCLC patients treated with nivolumab
    Koh, Yasuhiro
    Akamatsu, Hiroaki
    Mori, Keita
    Kanai, Kuninobu
    Hayata, Atsushi
    Tokudome, Nahomi
    Higuchi, Masayuki
    Akamatsu, Keiichiro
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    CANCER RESEARCH, 2018, 78 (13)
  • [5] Sequential tracking of PD-L1 expression on circulating tumor cells in NSCLC patients treated with nivolumab
    Akamatsu, Hiroaki
    Koh, Yasuhiro
    Mori, Keita
    Kanai, Kuninobu
    Hayata, Atsushi
    Tokudome, Nahomi
    Higuchi, Masayuki
    Kanbara, Hlsashige
    Akamatsu, Keiichiro
    Nakanishi, Masanori
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [6] Longitudinal evaluation of PD-L1 expression on circulating tumor cells in advanced NSCLC patients treated with nivolumab
    Sato, Koichi
    Koh, Yasuhiro
    Ikeda, Mio
    Akamatsu, Hiroaki
    Ueda, Hiroki
    Yamamoto, Nobuyuki
    CANCER SCIENCE, 2021, 112 : 533 - 533
  • [7] Predictive and prognostic value of tumor cells and circulating plasma free DNA in advanced epithelial ovarian carcinoma
    Martinez-Garcia, J.
    Minguela Puras, A.
    Cascales Campos, P. A.
    Martinez Sanchez, M. V.
    Gil Martinez, J.
    Barcelo Valcarcel, F.
    Rodriguez Hernandez, J. R.
    Torroba Caron, M. A.
    Soto-Gutierrez, A.
    Sanchez Henarejos, P.
    Puertes Boix, A.
    Montenegro Luis, S.
    Ruiz Carreno, P.
    Rodriguez Braun, E.
    Jimenez Lucas, M. D.
    Guirao Marin, M.
    Cuellar Rivas, M. A.
    Cano Jimenez, A.
    Anton Garcia, A.
    Alonso Romero, J. L.
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Circulating Tumor Cells and Metabolic Parameters in NSCLC Patients Treated with Checkpoint Inhibitors
    Castello, Angelo
    Carbone, Francesco Giuseppe
    Rossi, Sabrina
    Monterisi, Simona
    Federico, Davide
    Toschi, Luca
    Lopci, Egesta
    CANCERS, 2020, 12 (02)
  • [9] Circulating Tumor Cells and Circulating Tumor DNA in Patients with PseudoMyxoma Peritonei
    Dazza, Marie
    Toure, Emmanuel
    Blanchard, France
    Paresy, Marianne
    Sarafan-Vasseur, Nasrin
    Sabourin, Jean-Christophe
    LABORATORY INVESTIGATION, 2016, 96 : 168A - 169A
  • [10] Circulating Tumor Cells and Circulating Tumor DNA in Patients with PseudoMyxoma Peritonei
    Dazza, Marie
    Toure, Emmanuel
    Blanchard, France
    Paresy, Marianne
    Sarafan-Vasseur, Nasrin
    Sabourin, Jean-Christophe
    MODERN PATHOLOGY, 2016, 29 : 168A - 169A
12345